Eli Lilly Addresses Unauthorized Sales of New Obesity Drug | Retatrutide News

Eli Lilly is targeting unauthorized sales of its new obesity drug to ensure safety and regulatory compliance. This highlights the challenges in distribu...
Market News · October 19, 2026